Select Filters
Apply Filters

Investigating Tau Biology and Toxicity in Glia

Oyinkan Adesakin, Ph.D.
Brighton, United Kingdom
2019

Understanding the Impact of a Late-Onset Alzheimer's Disease Mutation in CD2AP on Synapses

Claudia Almeida, Ph.D.
Lisbon, Portugal
2019

Hypothalamic dysfunction as a driver of age-related cognitive decline

Ahmad Aziz, M.D., Ph.D.
Bonn, Germany
2019

Glial Control of the Local Neuronal Translatome in Alzheimer's Disease

Jimena Baleriola Gomez De Pablos, Ph.D.
Leioa, Spain
2019

Systemic Inflammation as a Factor to Influence Alzheimer’s Disease

Tatiana Barichello, Ph.D.
Houston, TX - United States
2019

AD Biomarker and Risk Characterization in Cognitively Unimpaired Middle-Age

Tobey Betthauser, Ph.D.
Madison, WI - United States
2019

Nup153 as target to improve neurogenesis and cognitive function in AD

Claudia Colussi, Ph.D.
Rome, Italy
2019

Telomeres and cognitive decline in subjects at risk of Alzheimer's disease

Marta Crous-Bou, Ph.D.
Barcelona, Spain
2019

Generation of Human Cerebral Organoids to Model Alzheimer’s Disease

Luz Karina Cuanalo Contreras, Ph.D.
Houston, TX - United States
2019

RCT with a Ketone Ester Drink in MCI

Stephen Cunnane, Ph.D.
Sherbrooke, Canada
2019

Insulin resistance and inflammation in Alzheimer's: The role of soluble TNF

Maria Elizabeth De Sousa Rodrigues, Ph.D.
Atlanta, GA - United States
2019

LPC DHA as Novel Nutraceutical Approach for Prevention of Alzheimer Disease

Sugasini Dhavamani, Ph.D.
Chicago, IL - United States
2019

Disruption of 3D-genome structure in Alzheimer’s Disease

Vishnu Dileep, Ph.D.
Cambridge, MA - United States
2019

ACSS2 and the Metabolic-Epigenetic Axis in Alzheimer's Disease

Gabor Egervari, M.D., Ph.D.
Philadelphia, PA - United States
2019

Identifying Cognitive and Health-Related Biomarkers for Dementia in Congo

Jean Ikanga, Ph.D.
Atlanta, GA - United States
2019

TMEM106b as a lysosomal safeguard of cognitive function

Joanna Jankowsky, Ph.D.
Houston, TX - United States
2019

Developing HDAC6 inhibitors as novel therapeutics for Alzheimer's Disease

Janice Kranz, Ph.D.
Cambridge, MA - United States
2019

Study of tau strains to understand the phenotypic diversity in AD

Aurelien Lathuiliere, M.D., Ph.D.
Boston, MA - United States
2019

Targeting FNDC5/irisin to improve brain metabolism in Alzheimer’s disease

Mychael Lourenco, Ph.D.
Rio de Janeiro, Brazil
2019

Rejuvenating Microglia in a Mouse Model of Alzheimer’s Disease

Anna Majewska, Ph.D.
Rochester, NY - United States
2019

Neuroinflammation in Alzheimer's disease

Andreea Manole, Ph.D.
La Jolla, CA - United States
2019

Development and Validation of a Mobile Cognitive Assessment Tool

Dawn Mechanic-Hamilton, Ph.D.
Philadelphia, PA - United States
2019

Characterizing Dementia Caregiver Stress and Its Far-Reaching Impacts

Oanh Meyer, Ph.D.
Davis, CA - United States
2019

Role of C99 in the Lipid Dyshomeostasis in Alzheimer's Disease

Jorge Montesinos, Ph.D.
New York, NY - United States
2019

Circadian Rhythm, Sleep, and Brain in Aging

Chooza Moon, Ph.D.
Iowa City, IA - United States
2019

Bosutinib effects on safety, biomarkers and clinical outcomes in DLB

Charbel Moussa, M.D., Ph.D.
Washington, DC - United States
2019

Investigating calcium dysregulation at the synapse in Alzheimer’s disease

Farr Niere, Ph.D.
Winston-Salem, NC - United States
2019

Elucidating the Effect of APOE4 Expression on Tauopathy in the EC

Tal Nuriel, Ph.D.
New York, NY - United States
2019

Clinical Evaluation of Allogenic Mesenchymal Stem Cells for Mild Alzheimer’s Disease

Anthony Oliva, Ph.D.
Miami, FL - United States
2019

Cis Phosphorylated Tau in the Development and Therapy of Vascular Dementia

Chenxi Qiu, Ph.D.
Boston, MA - United States
2019

1 2 3 4 5 6 7 8 9 10... >|